| Dr Robert James Pelfrey, MD | |
|
614 N Main St Ste B, Enterprise, AL 36330 | |
| (343) 348-8884 | |
| Not Available |
| Full Name | Dr Robert James Pelfrey |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 614 N Main St Ste B, Enterprise, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831123215 | NPI | - | NPPES |
| MD.7831 | Other | AL | ALABAMA LICENSE |
| 200337460A | Medicaid | OK | |
| 200505990K | Medicaid | OK | |
| 211693 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | G35838 (California) | Secondary |
| 208800000X | Urology | MD.7831 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert James Pelfrey, MD 4300 W Main St, Suite 102, Dothan, AL 36305-1054 Ph: (334) 793-9564 | Dr Robert James Pelfrey, MD 614 N Main St Ste B, Enterprise, AL 36330 Ph: (343) 348-8884 |
News Archive
IOS Press announces publication of a special issue of NeuroRehabilitation: An International Journal devoted specifically to hypoxic-ischemic brain injury (HI-BI), a significant disruption of brain function due to a deficient supply of oxygen to the brain.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has initiated a Phase 1B/2 dose-ranging clinical study with its anticoagulant reversing agent, PMX-60056. The study is intended to demonstrate the safety and efficacy of PMX-60056 in reversing varying heparin levels, including the highest levels commonly used in surgical settings.
Misfiring brain cells that control key parts of the mouth and tongue may be creating swallowing difficulties in children with neurodevelopmental disorders, according to neuroscientists with Virginia Tech and George Washington University.
MRI scans that detect shrinkage in specific regions of the mid-brain attacked by Alzheimer's disease accurately diagnose the neurodegenerative disease, even before symptoms interfere with daily function, a study by the Florida Alzheimer's Disease Research Center (ADRC) in Miami and Tampa found.
Although the health benefits of green space are supported by a growing body of evidence, few studies on this topic have been carried out in low- and middle-income countries.
› Verified 8 days ago